Literature DB >> 22489600

Effects of membrane lipids on the activity and processivity of purified γ-secretase.

Oliver Holmes1, Swetha Paturi, Wenjuan Ye, Michael S Wolfe, Dennis J Selkoe.   

Abstract

The 19-transmembrane multisubunit γ-secretase complex generates the amyloid β-peptide (Aβ) of Alzheimer's disease (AD) by intramembrane proteolysis of the β-amyloid precursor protein (APP). Despite substantial advances in elucidating how this protein complex functions, the effect of the local membrane lipid microenvironment on γ-secretase cleavage of substrates is still poorly understood. Using detergent-free proteoliposomes to reconstitute purified human γ-secretase, we examined the effects of fatty acyl (FA) chain length, saturation and double-bond isomerization, and membrane lipid polar headgroups on γ-secretase function. We analyzed γ-secretase activity and processivity [i.e., sequential cleavages in the APP transmembrane domain that convert longer Aβ species (e.g., Aβ(46)) into shorter ones (e.g., Aβ(40))] by quantifying the APP intracellular domain (AICD) and various Aβ peptides, including via a bicine/urea gel system that detects multiple Aβ lengths. These assays revealed several trends. (1) Switching from a cis to a trans isomer of a monounsaturated FA chain in phosphatidylcholine (PC) increased γ-activity, did not affect Aβ(42):Aβ(40) ratios, but decreased the ratio of long (≥42) versus short (≤41) Aβ peptides. (2) Increasing the FA carbon chain length (14, 16, 18, and 20) increased γ-activity, reduced longer Aβ species, and reduced the Aβ(42):Aβ(40) ratio. (3) Shifting the position of the double bond in 18:1(Δ9-cis) PC to the Δ6 position substantially reduced activity. (4) Gangliosides increased γ-activity but decreased processivity, thus elevating the Aβ(42):Aβ(40) ratio. (5) Phosphatidylserine decreased γ-activity but increased processivity. (6) Phosphatidylinositol strongly inhibited γ-activity. Overall, our results show that subtle changes in membrane lipid composition can greatly influence γ-secretase activity and processivity, suggesting that relatively small changes in lipid membrane composition may affect the risk of AD at least as much as presenilin or APP mutations do.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489600      PMCID: PMC3347702          DOI: 10.1021/bi300303g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s).

Authors:  W Taylor Kimberly; William P Esler; Wenjuan Ye; Beth L Ostaszewski; Jun Gao; Thekla Diehl; Dennis J Selkoe; Michael S Wolfe
Journal:  Biochemistry       Date:  2003-01-14       Impact factor: 3.162

3.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Neural membrane phospholipids in Alzheimer disease.

Authors:  K Wells; A A Farooqui; L Liss; L A Horrocks
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

5.  The role of presenilin cofactors in the gamma-secretase complex.

Authors:  Nobumasa Takasugi; Taisuke Tomita; Ikuo Hayashi; Makiko Tsuruoka; Manabu Niimura; Yasuko Takahashi; Gopal Thinakaran; Takeshi Iwatsubo
Journal:  Nature       Date:  2003-03-16       Impact factor: 49.962

6.  Dietary fats and the risk of incident Alzheimer disease.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Neelum Aggarwal; Julie Schneider; Robert S Wilson
Journal:  Arch Neurol       Date:  2003-02

7.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

8.  Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Authors:  D R Borchelt; G Thinakaran; C B Eckman; M K Lee; F Davenport; T Ratovitsky; C M Prada; G Kim; S Seekins; D Yager; H H Slunt; R Wang; M Seeger; A I Levey; S E Gandy; N G Copeland; N A Jenkins; D L Price; S G Younkin; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

9.  Diet and risk of dementia: Does fat matter?: The Rotterdam Study.

Authors:  M J Engelhart; M I Geerlings; A Ruitenberg; J C Van Swieten; A Hofman; J C M Witteman; M M B Breteler
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

10.  Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.

Authors:  Robert Ehehalt; Patrick Keller; Christian Haass; Christoph Thiele; Kai Simons
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  46 in total

1.  γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.

Authors:  Yong Ran; Pedro E Cruz; Thomas B Ladd; Abdul H Fauq; Joo In Jung; Julian Matthews; Kevin M Felsenstein; Todd E Golde
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

Review 2.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

3.  Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Authors:  Niklas Mattsson; Maria Olsson; Mikael K Gustavsson; Marko Kosicek; Martina Malnar; Jan-Eric Månsson; Maria Blomqvist; Johan Gobom; Ulf Andreasson; Gunnar Brinkmalm; Charles Vite; Silva Hecimovic; Caroline Hastings; Kaj Blennow; Henrik Zetterberg; Erik Portelius
Journal:  Metab Brain Dis       Date:  2012-09-01       Impact factor: 3.584

4.  Enzymatic Assays for Studying Intramembrane Proteolysis.

Authors:  D M Bolduc; D J Selkoe; M S Wolfe
Journal:  Methods Enzymol       Date:  2016-12-24       Impact factor: 1.600

5.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

6.  Effects of Chronic Photobiomodulation with Transcranial Near-Infrared Laser on Brain Metabolomics of Young and Aged Rats.

Authors:  Fabrízio Dos Santos Cardoso; Júlio César Claudino Dos Santos; Francisco Gonzalez-Lima; Bruno Henrique Silva Araújo; Rodrigo Álvaro Brandão Lopes-Martins; Sérgio Gomes da Silva
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

Review 7.  Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases.

Authors:  Emma L Clayton; Shane Minogue; Mark G Waugh
Journal:  Mol Neurobiol       Date:  2012-10-10       Impact factor: 5.590

8.  Longitudinal association between phosphatidylcholines, neuroimaging measures of Alzheimer's disease pathophysiology, and cognition in the Mayo Clinic Study of Aging.

Authors:  Danni Li; Clinton Hagen; Ashely R Fett; Hai H Bui; David Knopman; Prashanthi Vemuri; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  Neurobiol Aging       Date:  2019-03-18       Impact factor: 4.673

Review 9.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

10.  Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein.

Authors:  Ilker Karaca; Irfan Y Tamboli; Konstantin Glebov; Josefine Richter; Lisa H Fell; Marcus O Grimm; Viola J Haupenthal; Tobias Hartmann; Markus H Gräler; Gerhild van Echten-Deckert; Jochen Walter
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.